isoxsuprine has been researched along with Delayed Effects, Prenatal Exposure in 3 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazy, JE | 1 |
| Eckerman, CO | 1 |
| Gross, SJ | 1 |
| Finke, C | 1 |
| Laros, RK | 1 |
| Kitterman, JA | 1 |
| Heilbron, DC | 1 |
| Cowan, RM | 1 |
| Tooley, WH | 1 |
3 other studies available for isoxsuprine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Follow-up of infants of less than 1500 gm birth weight with antenatal isoxsuprine exposure.
Topics: Adult; Black People; Child Development; Female; Fetal Blood; Follow-Up Studies; Gestational Age; Hum | 1983 |
[Suspected mineralization disorders in the deciduous dentition after Duvadilan use during pregnancy (case reports)].
Topics: Child, Preschool; Female; Humans; Isoxsuprine; Pregnancy; Prenatal Exposure Delayed Effects; Tooth C | 1982 |
Outcome of very-low-birth-weight infants exposed to beta-sympathomimetics in utero.
Topics: Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Isoxsuprine; Longitudinal Studies; Pregna | 1991 |